Timken (NYSE: TKR) director sells 15,000 shares and receives RSU grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Timken Co director John M. Timken Jr. reported an open-market sale of 15,000 shares of common stock on May 8, 2026 at a weighted average price of $116.51 per share, executed in multiple trades between $116.48 and $117.25.
After this sale, he directly holds 264,744 common shares. On the same date, he also received a grant of 1,280 restricted share units, each tied to one share of common stock, which vest 100% one year from the grant date and are scheduled to expire on May 8, 2027.
In addition to his direct holdings, he reports various indirect interests through trusts and a spouse, some of which include explicit disclaimers of beneficial ownership.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 15,000 shares ($1,747,650)
Net Sell
9 txns
Insider
TIMKEN JOHN M JR
Role
null
Sold
15,000 shs ($1.75M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Share Unit | 1,280 | $0.00 | -- |
| Sale | Common Stock | 15,000 | $116.51 | $1.75M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Share Unit — 1,280 shares (Direct, null);
Common Stock — 264,744 shares (Direct, null);
Common Stock — 500 shares (Indirect, By Spouse)
Footnotes (1)
- This transaction was executed in multiple trades at prices ranging from $116.48 to $117.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. DISCLAIMER: Undersigned disclaims any beneficial interest. Trustee for Susan H. Timken Generation Skipping Trust. Beneficiary of John M. Timken Trust D FBO John M. Timken, Jr. Shares held in an Irrevocable Trust with spouse as sole lifetime beneficiary. Director is not a trustee and has no beneficial interest. Trustee for Henry H Timken Jr Testamentary Trust FBO Jane M Timken. DISCLAIMER: Undersigned disclaims any beneficial ownership. Trustee for Henry H Timken Jr Testamentary Trust FBO John M Timken Jr. DISCLAIMER: Undersigned disclaims beneficial ownership, except for his lifetime income interest in the trust. Grant of restricted share units that vest 100% one year from date of grant.
Key Figures
Shares sold: 15,000 shares
Weighted average sale price: $116.51/share
Sale price range: $116.48–$117.25/share
+3 more
6 metrics
Shares sold
15,000 shares
Open-market sale of common stock on May 8, 2026
Weighted average sale price
$116.51/share
Open-market sale executed in multiple trades
Sale price range
$116.48–$117.25/share
Price range for the 15,000-share sale
Direct shares after sale
264,744 shares
Common stock directly held after transactions
RSUs granted
1,280 units
Restricted share units granted May 8, 2026
RSU expiration date
May 8, 2027
Scheduled expiration of restricted share units
Key Terms
Restricted Share Unit, open-market sale, Generation Skipping Trust, beneficial ownership, +1 more
5 terms
open-market sale financial
"transaction_action: "open-market sale" for 15,000 common shares"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Generation Skipping Trust financial
"Trustee for Susan H. Timken Generation Skipping Trust."
beneficial ownership regulatory
"DISCLAIMER: Undersigned disclaims any beneficial ownership."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
beneficial interest regulatory
"DISCLAIMER: Undersigned disclaims any beneficial interest."
Beneficial interest is the right to receive the economic benefits of an asset—such as dividends, interest, or sale proceeds—without necessarily holding legal title to it. For investors this matters because it determines who actually gains from an investment or trust, much like renting an apartment where the tenant enjoys living there and paying bills while the landlord holds the deed; understanding who has the beneficial interest affects income rights, voting influence, and risk exposure.
FAQ
What did Timken (TKR) director John M. Timken Jr. report in this Form 4?
He reported one sale and one equity grant. John M. Timken Jr. sold 15,000 Timken common shares and received 1,280 restricted share units, both dated May 8, 2026, while disclosing his updated direct and indirect holdings.
What are John M. Timken Jr.’s direct Timken (TKR) holdings after the sale?
He directly holds 264,744 Timken shares after the sale. The Form 4 shows this post-transaction balance of common stock, reflecting his remaining direct ownership following the 15,000-share open-market disposition.
Does John M. Timken Jr. have indirect Timken (TKR) holdings?
Yes, he reports multiple indirect interests. The Form 4 lists shares held as trustee, advisor, beneficiary of various trusts, and by his spouse, with footnotes including several disclaimers of beneficial ownership or beneficial interest.
How is the Timken (TKR) sale price range described in the Form 4 footnotes?
The sale was executed in multiple trades within a narrow band. Footnote disclosure states trades occurred between $116.48 and $117.25 per share, with $116.51 reported as the weighted average sale price for the 15,000 shares.